Japanese Pharmaceutical Market & Registration Strategies- Part 2
The second article in the series focuses on strategies for success in registering products on the Japanese market.
November 12, 2024
by Deepak Hegde
Japanese Pharmaceutical Market & Registration Strategies – Part 1
The article provides an outline of characteristics、Regulatory bodies、 Pricing、Reimbursement、the process of registering an innovative drug and generic drugs in Japan.
November 12, 2024
by Deepak Hegde
Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 2)
Influenza is an acute respiratory infectious disease caused by the influenza virus.
July 12, 2024
by Xiaomichong
Based on the Current Status of Drug Research and Development Targeting the Pathogenesis of Influenza (Part 1)
Influenza is an acute respiratory infectious disease caused by the influenza virus.
July 12, 2024
by Xiaomichong
Packaging Management of Drug Products for Clinical Use
Pharma products for clinical purposes also require specialized packaging procedures compared to commercial products.
March 21, 2023
by Muhammad Asim Niazi
IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation
The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay.
March 10, 2023
by PharmaSources
US healthcare groups publish drug supply chain recommendations
American healthcare groups have released a series of policy and marketplace recommendations to address significant challenges in the US drug supply chain.
December 23, 2021
by EuropeanPharmaceuticalReview
Press Release Eupraxia Pharmaceuticals Announces Filing of Preliminary Base Shelf Prospectus
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has filed and obtained a receipt for a preliminary short form...
December 14, 2021
by FirstWordPharma
NewsPoints Former DEA official helped pharma company get drug quota increase, says watchdog
According to the US Justice Department's internal watchdog, a former senior official at the Drug Enforcement Administration (DEA) improperly gave preferential treatment to a pharmaceutical company that was seeking a quota increase so it could...
December 3, 2021
by FirstWordPharma
Vice-premier stresses accelerating COVID-19 drug research
BEIJING — Vice-Premier Sun Chunlan has urged more efforts to accelerate the research and development of COVID-19 drugs and strive for breakthroughs so as to safeguard people's health.
October 21, 2021
by NMPA
20 Best-selling Drugs in the World by 2025
2020, the year of the COVID-19 pandemic, presented significant challenges to every market in the world. However, the pharmaceutical market has still been able to adapt to this new situation and continues to grow quickly.
August 25, 2021
by Lin Zhang
Introduction of FDA Regulatory Education for Industry (REdI) Annual Conference 2021
There are many educational events in FDA throughout the year that focus on the pharmaceutical and regulatory industries.
August 16, 2021
by Lin Zhang